It was reported that a patient experienced wound dehiscence and subsequent infection coincident with the use of veritas.The patient had a bilateral prophylactic skin sparing mastectomy and direct to implant immediate reconstruction.Three weeks post operatively, there was a small wound dehiscence on one breast with an exposed implant.The surgeon referred the patient to a general practitioner to start on antibiotics (dose, route, duration, and frequency not reported) for the event.Two days later, it was noted that the same process was starting on the opposite breast.Within a couple of days, the dehiscence worsened, and the surgeon referred the patient to be admitted to the hospital for wound dressings and antibiotics (intravenously, dose, frequency, and duration not reported) for the event.Two days prior to the receipt of this report, the patient underwent surgery to have the implants removed.During the operation, the surgeon noted the veritas had bilaterally ripped in half, thus exposing the implant, which then eroded the underside of the wound leading to an infection.The implants have been removed and the patient is currently recovering on antibiotics (dose, route, duration, and frequency not reported).No additional information is available.
|
(b)(4).A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
|